Disability Benefits Guide
Multiple Myeloma and Disability Benefits
On This Page
Multiple myeloma can affect several systems at once: bone strength, blood-cell production, kidney function and stamina. A disability application should connect the hematology record with those practical effects. A diagnosis, abnormal protein result or planned transplant alone does not answer every eligibility question.
Adults applying for SSDI or disability-based SSI generally must be unable to perform substantial gainful work because of an impairment lasting or expected to last at least 12 continuous months, or expected to result in death. SSDI has work-insurance requirements; SSI has income, resource and other rules.
Clarify the Plasma Cell Diagnosis
NCI distinguishes multiple myeloma from monoclonal gammopathy of undetermined significance, or MGUS, and from other plasma cell disorders. MGUS is not cancer. Some multiple myeloma is described as smoldering because it has no symptoms. These labels should not be used interchangeably in a claim.
Relevant records can include blood and urine protein studies, bone marrow findings, imaging, blood counts and kidney tests. NCI describes bone pain, fractures, infections, fatigue and other possible effects of myeloma. Include what your clinicians have actually found, rather than assuming every complication follows from the diagnosis.
SSA’s Multiple Myeloma Listing
Listing 13.07 calls for confirmation through appropriate serum or urine protein electrophoresis and bone marrow findings. One alternative requires failure to respond or progressive disease after initial anticancer therapy. The other addresses bone marrow or stem cell transplantation.
For the transplant alternative, SSA considers disability until at least 12 months after transplantation, then evaluates residual impairments under the affected body systems. SSA’s explanatory rules require the transplantation to have occurred; scheduling or discussing it is not the same as completing it. Earlier disability onset may be supported by other evidence, so the clinical history before transplant still matters.
If the listing is not met, SSA considers other listings and medical equivalence. It may then evaluate residual functional capacity and the ability to perform past or other work. Documented bone damage, kidney disease, anemia or neurological limitations may remain important even when the myeloma responds to therapy.
Document the Course of Treatment
Myeloma care may include combinations of drug therapies, stem cell transplantation for selected patients, and treatment addressing bone or other complications. NCI describes induction treatment, possible consolidation and maintenance, but not every person follows the same sequence. Treatment choice depends on the disease and individual health.
Ask for a clear timeline showing the initial plan, treatments actually received, response measurements, changes and reasons for those changes. Continuing maintenance treatment is not automatically proof that initial treatment failed. Likewise, a response in laboratory measurements does not describe every remaining functional problem.
Record actual treatment effects such as fatigue, nausea, nerve symptoms or infection-related interruptions when they occur. NCI emphasizes that side effects vary. Report them to the care team; do not adjust cancer medicines or physical activity on the basis of a benefits guide.
Make Bone and Organ Limitations Concrete
- For fractures or painful bone lesions, provide imaging, treatment notes and any clinician-directed limits on lifting, bending, walking or standing.
- For fatigue, describe activity duration, rest needs and whether symptoms change across treatment cycles.
- For kidney complications, include the relevant specialist records and the practical requirements of any ongoing treatment.
- For infection or hospitalization, list dates, reasons, treatment and recovery time.
- Explain hand numbness, balance or concentration difficulties through the tasks they disrupt, if those problems are present.
SSA evaluates all established impairments together. A clinician’s explanation of findings and sustained limitations is more informative than an unsupported statement that the applicant is “disabled.” Work records can clarify reduced duties, assistance or attempts that could not be sustained.
Document cost or access barriers that prevented care, including attempts to obtain available help. SSA’s failure-to-follow-prescribed-treatment policy has specific prerequisites and good-cause rules; a care gap is not automatically a refusal of treatment or an automatic denial.
Common Questions
Does Mgus Meet the Myeloma Cancer Listing?
MGUS is a different diagnosis. SSA must evaluate the medically established condition and its effects under the appropriate rules, rather than relabeling it as multiple myeloma.
Does the Transplant Rule Mean Benefits Must End After a Year?
No. The listing directs SSA to evaluate residual impairments after the specified period. Continuing eligibility depends on the applicable review rules and evidence.
What Is the Approval Rate?
This guide does not convert cancer award shares into an individual probability. Read the approval-data guide to understand what historical figures can and cannot show.
Next Steps and Sources
Use the application guide and medical and work records checklist. If you have a decision, read its reasons and deadlines alongside the appeals guide.
Related reading: kidney disease, leukemia. Browse the condition directory.
Official Sources
- 13.00 Cancer – Adult[1]
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment – NCI
- Side Effects of Cancer Treatment – NCI
- Part I – General Information[2]
- How Does Someone Become Eligible?[3]
- Code of Federal Regulations § 404.1545[4]
- Part II – Evidentiary Requirements[5]
- SSR 18-3p[6]
General educational information, not individualized medical or legal advice. Disability Benefit Guide USA is not affiliated with the Social Security Administration. Read how our guides are prepared.
Official Sources and References
These SSA.gov links support the explanations above. Official applications, account services, and agency forms are completed through SSA.
- 13.00 Cancer – Adult — SSA.gov
- Part I – General Information — SSA.gov
- How Does Someone Become Eligible? — SSA.gov
- Code of Federal Regulations § 404.1545 — SSA.gov
- Part II – Evidentiary Requirements — SSA.gov
- SSR 18-3p — SSA.gov